Multifocal iris melanoma treated with total anterior segment palladium-103 plaque radiation therapy

Petousis, Vasileios; Finger, Paul T.; Milman, Tatyana

doi:10.1007/s00417-010-1590-8

Cited by 27 publications

(21 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Petousis et al 11 realised anterior segment irradiation for iris melanoma with a palladium plaque and a favourable course during 1-year follow-up.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Proton beam radiotherapy of diffuse iris melanoma in 54 patients

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Petousis et al 11 realised anterior segment irradiation for iris melanoma with a palladium plaque and a favourable course during 1-year follow-up.…”

Section: Discussionmentioning

confidence: 99%

“…Iodine-125 plaque treatment delivers a higher dose to the cornea, which is even higher in palladium-103 and ruthenium-106 brachytherapy 11 12. Brachytherapy generally exposes the patient to surgery and in-patient treatment, which is not needed in PBR.…”

Section: Discussionmentioning

confidence: 99%

Proton beam radiotherapy of diffuse iris melanoma in 54 patients

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Nowadays, Pd 103 is used in oncology, in brachytherapy for prostate cancer (4)(5)(6) and ocular melanoma (7)(8)(9). The latest research indicated that some palladium complexes were effective in the treatment of non-small-cell lung cancer (10), breast cancer (11,12) and ovarian cancer (13).…”

Section: Introductionmentioning

confidence: 99%

Cardiotoxicity of Palladium Compounds / Kardiotoksičnost Jedinjenja Paladijuma

Peric¹,

Janković²

2013

Journal of Medical Biochemistry

View full text Add to dashboard Cite

SummaryPrevious studies have shown that palladium has toxic effects on the kidney and liver, leads to deterioration of the general condition of animals, and could cause allergy in animals and humans. Considering the limited data about the influence of palladium on the cardiovascular system, the aim of our study was to evaluate the effects of palladium on the heart from available published data, and to compare the toxicity of inorganic and organic palladium compounds. Relevant studies for our review were identified from PubMed and Scopus databases. The search terms included »palladium «, »palladium compound«, »cardiotoxicity«, »toxicity«, »heart«, »myocardium«, »oxidative stress« and »myocardial enzyme«, as well as combinations of these terms. There were only two published studies with the primary purpose to investigate the effect of palladium on the cardiovascular system, while others registered the side-effects of palladium compounds on the heart. Palladium could cause arrhythmias, a drop in blood pressure, decrease of the heart rate, as well as death of experimental animals. Based on the presented data it seems that palladium does not express significant cardiac toxicity when it is bound in an organic compound. Further investigation of the effects of palladium on the heart is necessary for a clear picture of the nature and extent of its cardiac toxicity.

show abstract

“…В тече-ние длительного времени энуклеация была единственным предлагаемым способом лечения при диффузном росте опухоли, нерезектабель-ном объеме поражения и сопутствующей вто-ричной гипертензией. В последние годы появи-лись публикации о возможности использования лучевых методов в лечении больных с означен-ной патологией, в числе которых и наши рабо-ты, которые демонстрируют высокую эффек-тивность и относительную безопасность локаль-ного облучения опухоли радиоактивными оф-тальмоаппликаторами (ОА) [9][10][11][12][13][14][15].…”

unclassified